
Swedish Orphan Biovitrum AB (publ): management transactions · Finland · FIN-FSA
FI:swedish-orphan-biovitrum-ab-publ-e3c7bcSE0000872095FIFI·FIN-FSAMcap 150.8Bn€Healthcare
Browse the full insider trade history of Swedish Orphan Biovitrum AB (publ), a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Swedish Orphan Biovitrum AB (publ) has recorded 8 reports. Market capitalisation: €150.8bn. The latest transaction was filed on 25 March 2026 — Purchase. Among the most active insiders: Guido Oelkers. All data is openly available.
€446,604
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
Analyst consensus
13 analysts308.00 €Target 456.77 €(+5%)530.00 €
Income statement
Revenue28.24 Bn€
Gross profit21.99 Bn€78% margin
Net income478.0 M€3.2% margin
Valuation
PER (trailing)167.0x
PER (forward)19.3x
P/Book3.7x
Beta0.26
Balance sheet & cash
Market cap150.78 Bn€
Total debt11.49 Bn€
Free Cash Flow5.41 Bn€
Debt / Equity47%
Profitability & ownership
ROE2.3%
ROA7.0%
% insiders10.1%
% institutions73.3%
Last declaration on 25 March 2026